Liver Systems in Safety Pharmacology

Liver is a vital organ in the body and plays a pivotal role in the regulation of metabolism, metabolism, and toxicity of drugs. This comprehensive book chapter delves into various aspects of liver function, metabolism, and toxicity assessment in the context of drug development. Beginning with an overview of the liver’s role in drug metabolism and its importance in ensuring drug safety, the discussion progresses to explore the intricacies of liver metabolism and drug biotransformation, including the phases of metabolism and the involvement of enzymes and transporters. The assessment and mechanisms of hepatotoxicity are examined, distinguishing between different types and elucidating common causes and underlying mechanisms. Preclinical models for liver safety assessment are discussed, encompassing both in vitro and in vivo approaches, along with their limitations and advantages. Advances in liver-on-a-chip technology are highlighted, showcasing the design, applications, and success stories of these innovative devices in safety pharmacology. This book chapter also addresses biomarkers for liver safety assessment, emphasizing both traditional serum markers and emerging biomarkers for noninvasive monitoring of liver health. Regulatory considerations and guidelines from FDA and EMA are outlined, alongside challenges and recommendations for regulatory compliance. Future trends and innovations in the field, such as personalized medicine approaches and the integration of artificial intelligence, are explored, underscoring the evolving landscape of liver safety assessment in drug development. In conclusion, this book chapter summarizes key takeaways and emphasizes the importance of liver safety assessment in ensuring drug efficacy and patient safety. Future directions and challenges in the field are discussed, providing insights into the ongoing advancements and opportunities for improvement in liver safety assessment practices.